AIMD Key Statistics, Chart & Performance
The current stock price of AIMD is 1.77 USD. In the past month the price decreased by -12.89%. In the past year, price decreased by -49.22%.
AIMD Technical Analysis
AIMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AIMD. AIMD may be in some trouble as it scores bad on both profitability and health.
AIMD Financial Highlights
Over the last trailing twelve months AIMD reported a non-GAAP Earnings per Share(EPS) of -4.29. The EPS increased by 68.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -65.95% | ||
| ROE | -148.9% | ||
| Debt/Equity | 1.1 |
AIMD Forecast & Estimates
AIMD Ownership
About AIMD
Company Profile
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Company Info
AINOS INC
3050 Post Oak Blvd,, Suite 510-T80
Houston TEXAS US
Employees: 44
Phone: 12818986586
AINOS INC / AIMD FAQ
Can you describe the business of AINOS INC?
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
What is the current price of AIMD stock?
The current stock price of AIMD is 1.77 USD. The price increased by 2.31% in the last trading session.
Does AINOS INC pay dividends?
AIMD does not pay a dividend.
What is the ChartMill rating of AINOS INC stock?
AIMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does AINOS INC belong to?
AINOS INC (AIMD) operates in the Information Technology sector and the Technology Hardware, Storage & Peripherals industry.
Can you provide the PE ratio for AIMD stock?
AINOS INC (AIMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.29).
Can you provide the upcoming earnings date for AINOS INC?
AINOS INC (AIMD) will report earnings on 2026-03-05.